Odevixibat is indicated for the treatment of pruritus in patients with PFIC aged 3 months and older.
Use RestrictionOdevixibat may be ineffective in a subgroup of patients with PFIC type 2 who have specific ABCB11 variants resulting in non-functional or complete absence of the bile salt export pump protein.
Odevixibat is indicated for the treatment of cholestatic pruritus in patients with ALGS aged 12 months and older.
FDA,2025.03